- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: N.331, Q.580, L.582
Ligand excluded by PLIPNAG.5: 5 residues within 4Å:- Chain A: F.342, N.343, V.367, S.371, F.374
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.603, T.604
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.9: 4 residues within 4Å:- Chain A: N.706, N.707, G.1128
- Chain B: D.793
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain A: N.798, S.800, Q.801
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: A.703, E.1069, N.1071
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: F.59, N.61
Ligand excluded by PLIPNAG.15: 8 residues within 4Å:- Chain A: N.122, T.124, N.125, V.126, V.127, M.153, E.154, F.157
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: E.281, N.282
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain B: N.331, Q.580, L.582
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain B: F.342, N.343, V.367, S.371, F.374
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain B: N.603, T.604
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: N.706, N.707, G.1128
- Chain C: D.793
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain B: K.792, N.798, S.800, Q.801
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.1131
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain B: N.122, T.124, N.125, V.126, V.127, F.157
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: E.281, N.282
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: N.331, Q.580, L.582
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain C: F.342, N.343, V.367, S.371, F.374
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: N.603, T.604
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: N.616, T.618
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: D.793
- Chain C: N.706, N.707, G.1128
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: A.703, E.1069, N.1071
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.1131
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: F.59, N.61
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain C: N.122, T.124, N.125, E.154, F.157
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: E.281, N.282
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes. Immunity (2022)
- Release Date
- 2022-12-07
- Peptides
- Spike glycoprotein: ABC
M8a-31 Fab heavy chain: DFH
M8a-31 Fab light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
MH
PE
LG
NI
Q
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, C. et al., Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes. Immunity (2022)
- Release Date
- 2022-12-07
- Peptides
- Spike glycoprotein: ABC
M8a-31 Fab heavy chain: DFH
M8a-31 Fab light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
MH
PE
LG
NI
Q